Papers
1
Total Citations
2
H-Index
1
About
Nada Shaker is a pathologist whose research focuses on the diagnostic challenges and histopathological nuances of renal cell carcinoma (RCC), particularly rare and aggressive subtypes. Her most-cited work examines the MiTF/TFE3 family translocation-associated subtype of RCC, a tumor driven by gene fusions involving transcription factors TFE3 or TFEB. In a detailed 2022 case report, Shaker described a 20-year-old male presenting with flank pain and hematuria—initially misattributed to nephrolithiasis—whose renal mass biopsy revealed spindle cells and mature fat without malignant cells, underscoring the diagnostic pitfalls of this entity. By correlating histology with MRI findings, she highlighted how translocation RCC can mimic benign lesions, emphasizing the need for molecular confirmation. This contribution aids pathologists and urologists in recognizing atypical presentations, reducing misdiagnosis. While her citation count remains modest, Shaker’s work addresses a critical gap in the literature on rare renal tumors, offering practical guidance for clinical practice. Her research exemplifies the importance of vigilance in renal pathology, particularly for young patients where timely, accurate diagnosis can alter management and prognosis.
Research Focus
Key Achievements
Top Papers
- 1Renal cell carcinoma, MiTF/TFE3 family translocation-associated subtype2 citations · 2022